Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
Brief Summary: Ve-cadherin is expressed in endothelial cells. Systemic slerosis is a rare auto-immune disease with a endothelial dysfunction. This study is to evaluated the level of soluble VE-cadherin and VE-cadherin antibody in patients with systemic slerosis.